Alector, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALEC research report →
Companywww.alector.com
Alector, Inc. , a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.
- CEO
- Arnon Rosenthal
- IPO
- 2019
- Employees
- 175
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $235.37M
- P/E
- -1.87
- P/S
- 12.78
- P/B
- 22.58
- EV/EBITDA
- -1.55
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 88.68%
- Op Margin
- -741.33%
- Net Margin
- -680.83%
- ROE
- -295.17%
- ROIC
- -65.15%
Growth & Income
- Revenue
- $21.05M · -79.07%
- Net Income
- $-142,929,000 · -20.06%
- EPS
- $-1.39 · -13.01%
- Op Income
- $-145,807,000
- FCF YoY
- 20.37%
Performance & Tape
- 52W High
- $3.40
- 52W Low
- $1.09
- 50D MA
- $2.31
- 200D MA
- $2.10
- Beta
- 0.65
- Avg Volume
- 708.45K
Get TickerSpark's AI analysis on ALEC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 16, 26 | Wong-Sarad Grace | sell | 1,820 |
| Mar 13, 26 | Rosenthal Arnon | other | 116,246 |
| Mar 15, 26 | Berkley Neil Lindsay | other | 54,600 |
| Mar 10, 26 | Wong-Sarad Grace | sell | 1,000 |
| Mar 3, 26 | Wong-Sarad Grace | sell | 3,367 |
| Mar 2, 26 | Wong-Sarad Grace | sell | 8,071 |
| Mar 2, 26 | Rosenthal Arnon | sell | 81,864 |
| Mar 2, 26 | Berkley Neil Lindsay | sell | 29,649 |
| Feb 26, 26 | Wong-Sarad Grace | sell | 4,079 |
| Dec 5, 25 | Wong-Sarad Grace | sell | 4,753 |
Our ALEC Coverage
We haven't published any research on ALEC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ALEC Report →